Concord Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 09, 2025
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech Limited has submitted the proceedings of its Annual General Meeting (AGM) held on September 9, 2025, to the stock exchange as a regulatory disclosure. AGM proceedings filings typically cover key shareholder approvals such as adoption of financial statements, declaration of dividend, reappointment of directors, ratification of auditor appointments, and any special resolutions. The detailed voting results and specific resolutions passed would be enclosed with the filing.
This is a routine regulatory filing with no direct material impact on stock price. Investors should review the enclosed voting results and resolutions for any meaningful decisions on dividends, capital actions, or governance changes.